Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA.
Cancer Informatics Core, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA.
Nat Commun. 2019 Mar 20;10(1):1280. doi: 10.1038/s41467-019-09263-1.
Understanding the intrinsic mediators that render CD8 T cells dysfunctional in the tumor microenvironment is a requirement to develop more effective cancer immunotherapies. Here, we report that C/EBP homologous protein (Chop), a downstream sensor of severe endoplasmic reticulum (ER) stress, is a major negative regulator of the effector function of tumor-reactive CD8 T cells. Chop expression is increased in tumor-infiltrating CD8 T cells, which correlates with poor clinical outcome in ovarian cancer patients. Deletion of Chop in T cells improves spontaneous antitumor CD8 T cell immunity and boosts the efficacy of T cell-based immunotherapy. Mechanistically, Chop in CD8 T cells is elevated primarily through the ER stress-associated kinase Perk and a subsequent induction of Atf4; and directly represses the expression of T-bet, a master regulator of effector T cell function. These findings demonstrate the primary role of Chop in tumor-induced CD8 T cell dysfunction and the therapeutic potential of blocking Chop or ER stress to unleash T cell-mediated antitumor immunity.
了解内在介质,使 CD8 T 细胞在肿瘤微环境中功能失调,是开发更有效的癌症免疫疗法的必要条件。在这里,我们报告称,C/EBP 同源蛋白(Chop)是严重内质网(ER)应激的下游传感器,是肿瘤反应性 CD8 T 细胞效应功能的主要负调节剂。Chop 在肿瘤浸润 CD8 T 细胞中的表达增加,这与卵巢癌患者的不良临床结局相关。在 T 细胞中删除 Chop 可改善自发抗肿瘤 CD8 T 细胞免疫,并增强基于 T 细胞的免疫疗法的疗效。从机制上讲,CD8 T 细胞中的 Chop 主要通过 ER 应激相关激酶 Perk 和随后诱导的 Atf4 升高;并直接抑制 T 细胞功能的主调控因子 T-bet 的表达。这些发现表明 Chop 在肿瘤诱导的 CD8 T 细胞功能失调中的主要作用,以及阻断 Chop 或 ER 应激以释放 T 细胞介导的抗肿瘤免疫的治疗潜力。